Who invested in New Haven Pharmaceuticals?
New Haven Pharmaceuticals's investors include Horizon Technology Finance, Connecticut Innovations, Advantage Capital, Kuzari Group and EJ Funds.
United States · Funded startup
4 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow New Haven Pharmaceuticals and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$26Mraised across 4 rounds since 2012, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $12M sold, first sale Oct 2014
Reported by masshightech.comSEC filing: $6.5M sold, first sale Sept 2012
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
New Haven Pharmaceuticals's investors include Horizon Technology Finance, Connecticut Innovations, Advantage Capital, Kuzari Group and EJ Funds.
New Haven Pharmaceuticals has raised $26M across 4 rounds since 2012.
New Haven Pharmaceuticals's most recent round was a Debt of $6.3M in Oct 2015.
New Haven Pharmaceuticals's largest round on record is $12M (Venture), in Oct 2014.
New Haven Pharmaceuticals's first round on record, in Oct 2012, was backed by Connecticut Innovations, Advantage Capital and Kuzari Group and 1 others.
New Haven Pharmaceuticals's latest named round is a Debt, in Oct 2015.
New Haven Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.